glp 1 medication retatrutide Retatrutide: A Promising Option for Non-Diabetic Weight Loss in Clinical Trials 🧬 Retatrutide is being called

Improvements in post-challenge lipid response following tirzepatide treatment in patients with type 2 diabetes

Losing fat while preserving lean mass is very different from simply losing weight

24 GLP-1-based treatments may be associated not just with fat loss but also reduced lean mass, including possible muscular atrophy

A retrospective cohort study on the effects of glucagon-like peptide 1 receptor agonist use on the risk of different obesity-associated malignancies

Consult Your Healthcare Provider: If constipation persists or becomes bothersome, don't hesitate to discuss it with your healthcare provider

J Diabetes Investig 10:1430